# CBD-Microglia PET Study

> **NCT04398719** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 28 (actual)

## Conditions studied

- CBD
- Healthy

## Interventions

- **RADIATION:** [11C]PBR28
- **DRUG:** Low-dose lipopolysaccharide
- **DRUG:** Intradermal Capsaicin

## Key facts

- **NCT ID:** NCT04398719
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-07
- **Primary completion:** 2024-12-11
- **Final completion:** 2024-12-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398719, "CBD-Microglia PET Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04398719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*